Emery-Dreifuss muscular dystrophy with dilated cardiomyopathy preceding skeletal muscle symptoms

Koichi Takamizawa1, Ki-Sung Kim1, Hideaki Ueda1

  • 1Department of Cardiology, Kanagawa Children's Medical Center, Yokohama, Japan.

Cardiology in the Young
|November 25, 2021
PubMed

Insights

Emery-Dreifuss muscular dystrophy, a progressive muscle and joint disorder, can present with cardiac issues like dilated cardiomyopathy. Genetic testing for LMNA mutations is key, especially when muscle weakness is minimal.

Area of Science:

  • Cardiology
  • Genetics
  • Neurology

Background:

  • Emery-Dreifuss muscular dystrophy (EDMD) is a rare genetic disorder characterized by progressive muscle and joint contractures.
  • Cardiac complications, including dilated cardiomyopathy and arrhythmias, are significant features of EDMD.
  • Diagnosis can be challenging due to slowly progressive skeletal muscle weakness.

Observation:

  • A case study of an 8-year-old girl with Emery-Dreifuss muscular dystrophy is presented.
  • Dilated cardiomyopathy was the initial clinical manifestation in this patient.
  • Muscle and myocardial biopsies showed normal results, complicating initial diagnosis.

Findings:

  • Genetic testing identified mutations in the LMNA gene.
  • LMNA mutations are a known cause of EDMD and related cardiomyopathies.
  • This case highlights the importance of genetic analysis in diagnosing EDMD.

Implications:

  • Cardiac manifestations can be the primary presenting symptom of EDMD.
  • Early diagnosis of EDMD through genetic testing is crucial for managing cardiac risks.
  • This case underscores the utility of genetic testing in identifying EDMD, even with subtle muscular symptoms.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
63
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
93
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
122
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
99
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.3K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K